bioRxiv preprint doi: https://doi.org/10.1101/2020.05.22.111294; this version posted September 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Preprinting the COVID-19 pandemic 2 3 Nicholas Fraser1,#, Liam Brierley2,#, Gautam Dey3,4, Jessica K Polka5, Máté Pálfy6, Federico Nanni7 & 4 Jonathon Alexis Coates8,9,* 5 6 7 1 Leibniz Information Centre for Economics, Düsternbrooker Weg 120, 24105 Kiel, Germany 8 2 Department of Health Data Science, University of Liverpool, Brownlow Street, Liverpool, L69 3GL, 9 UK 10 3 MRC Lab for Molecular Cell Biology, UCL, Gower Street, London WC1E 6BT, UK 11 4 Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstr. 1, 69117 12 Heidelberg, Germany 13 5 ASAPbio, 3739 Balboa St # 1038, San Francisco, CA 94121, USA 14 6 The Company of Biologists, Bidder Building, Station Road, Histon, Cambridge CB24 9LF, UK 15 7 The Alan Turing Institute, 96 Euston Rd, London NW1 2DB, UK 16 8 Hughes Hall College, University of Cambridge, Wollaston Rd, Cambridge, CB1 2EW, UK 17 9 William Harvey Research Institute, Charterhouse Square Barts and the London School of Medicine 18 and Dentistry Queen Mary University of London, London, EC1M 6BQ, UK 19 20 # These authors contributed equally to this work 21 * Correspondence:
[email protected] 22 23 24 25 bioRxiv preprint doi: https://doi.org/10.1101/2020.05.22.111294; this version posted September 18, 2020.